Anzeige
Mehr »
Lynx Broker
Login
Freitag, 18.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoFitbit enlists Pfizer, Bristol-Myers Squibb to bring arrhythmia detection to its fitness trackers
DoBlocking tumor evolution to halt cancer drug resistance
DoProtein-degrading Plexium debuts with $28M to attack cancer, neurodegenerative disease
DoEuroBiotech Report-Healx and Abalos raise cash, Ipsen bags Blueprint drug, Gilead and ReNeuron
DoSyros cans solid tumor drug after seeing early clinical data
DoAstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC
DoNSF International buys up CRO Amarex
DoEuropean VC Sofinnova raises €333M for early-stage biotech, medtech firms
DoArsenalBio joins next-gen cell therapy field with $85M A round
DoClosed-loop artificial pancreas from Tandem, Dexcom aces type 1 diabetes study
MiNovartis' Sandoz drops out of prescription app deal with Pear Therapeutics
MiMedImmune's top cancer researcher jumps ship to small biotech
MiAlexion inks deal to acquire Achillion for $930M upfront
MiIpsen bags Blueprint drug to move deeper into ultra-rare disease
MiLilly's Armo buyout drug a bust in pancreatic cancer
MiRoche dumps early pipeline efforts as sales jump
MiHealx raises $56M to launch 40 rare disease R&D programs
DiPhilips to bring Spencer Health's digital pill hub to Europe
DiAbbott partners with Omada, Tandem to extend the reach of its FreeStyle Libre CGM
DiEli Lilly to shutter neuroscience R&D center next year
DiWoodford cut down as fund chopped and burned
DiBoehringer's VC wing backs anti-cancer virus startup
DiReata shocks analysts with pivotal win in Friedreich's ataxia
DiAeglea, long-term Eli Lilly veteran nabs CMO job at Checkmate
MoMarrying CRISPR with immuno-oncology to defeat remote tumors